文献速递湿疹皮炎与荨麻疹

每周患者报告症状监测对湿疹试验结局的影响:湿疹在线监测随机对照试验

Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial.
PubMed 文献 · Br J Dermatol · 2023-01-01

这项在线平行组非盲随机对照试验纳入296例湿疹患者,按1:1随机分为每周完成POEM监测7周的干预组或不进行POEM监测的对照组。第8周时,干预组POEM评分较对照组改善(平均差-1.64,95%CI -2.91至-0.38;P=0.01),但两组在标准外用治疗使用和随访数据完整性方面无组间差异。

要点

  • 每周POEM监测7周可使第8周POEM评分较不监测组小幅改善(平均差-1.64)。
  • 两组标准外用治疗使用和随访数据完整性无组间差异。
  • 每周症状监测可能构成非计划干预,设计湿疹试验时需考虑其影响。

核心结论

  • 每周患者报告症状监测带来了湿疹严重程度的小幅感知改善。

研究设计与样本

  • 在线平行组非盲随机对照试验,2021年9月14日至2022年1月16日在线招募296例湿疹患者(家长/照护者、青少年和成人),排除POEM评分<3分者。
  • 参与者按1:1在线随机分为每周完成POEM监测7周的干预组或不进行POEM监测的对照组,主要结局为基线与第8周POEM评分变化。
  • 分析按随机分组在完成第8周随访且有完整数据者中进行。

主要发现

  • 随访完成率为81.7%(n=242;干预组118/147,80.3%;对照组124/149,83.2%)。
  • 调整基线疾病严重程度和年龄后,干预组湿疹严重程度改善(POEM评分平均差-1.64,95%CI -2.91至-0.38;P=0.01)。
  • 两组标准外用治疗使用和随访数据完整性未见组间差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-reported outcome measures (PROMs) are commonly used in eczema clinical trials. Several trials have used PROMs weekly for symptom monitoring. However, the increased frequency of patient-reported symptom monitoring may prompt participants to enhance the self-management of eczema and increase standard topical treatment use that can lead to improvements in outcomes over time. This is concerning as weekly symptom monitoring may constitute an unplanned intervention, which may mask small treatment effects and make it difficult to identify changes in the eczema resulting from the treatment under investigation. OBJECTIVES: To evaluate the effect of weekly patient-reported symptom monitoring on participants' outcomes and to inform the design of future eczema trials. METHODS: This was an online parallel-group nonblinded randomized controlled trial. Parents/carers of children with eczema and young people and adults with eczema were recruited online, excluding people scoring < 3 points on the Patient Oriented Eczema Measure (POEM), to avoid floor effects. Electronic PROMs were used for data collection. Participants were allocated using online randomization (1 : 1) to weekly POEM for 7 weeks (intervention) or no POEM during this period (control). The primary outcome was change in eczema severity based on POEM scores, assessed at baseline and week 8. Secondary outcomes included change in standard topical treatment use and data completeness at follow-up. Analyses were conducted according to randomized groups in those with complete data at week 8. RESULTS: A total of 296 participants were randomized from 14 September 2021 to 16 January 2022 (71% female, 77% white, mean age 26.7 years). The follow-up completion rate was 81.7% [n = 242; intervention group, n = 118/147 (80.3%); control group n = 124/149 (83.2%)]. After adjusting for baseline disease severity and age, eczema severity improved in the intervention group (mean difference in POEM score -1.64, 95% confidence interval -2.91 to -0.38; P = 0.01). No between-group differences were noted in the use of standard topical treatments and data completeness at follow-up. CONCLUSIONS: Weekly patient-reported symptom monitoring led to a small perceived improvement in eczema severity.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Baker A, Mitchell EJ, Partlett C, et al. Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial. Br J Dermatol. 2023. PMID: 37194567. doi:10.1093/bjd/ljad163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。